New drug could change kidney transplants forever
Disease control
Not yet recruiting
This study tests a new drug called VEL-101 in 120 kidney transplant patients. The goal is to see if VEL-101 can safely replace the standard drug tacrolimus, which often causes side effects. Researchers will monitor for rejection, side effects, and how the drug behaves in the body…
Phase: PHASE2 • Sponsor: Veloxis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC